Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Diamond: Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascu.... (0.14 sec) 

Uncertain effects of rosiglitazone on the risk for myocardial infarction and cardiovascular …

- annals.org
GA Diamond, L Bax, S Kaul - Annals of Internal Medicine, 2007 - Am Coll Physicians
A recent, widely publicized meta-analysis of 42 clinical trials concluded that
rosiglitazone was associated with an approximately 43% increased risk for
myocardial infarction and an approximately 64% increased risk for ...
Cited by 119 - Related articles - BL Direct - All 5 versions

Coronary heart disease outcomes in patients receiving antidiabetic agents


AT McAfee, C Koro, J Landon, N Ziyadeh, AM … - Pharmacoepidemiology and Drug Safety, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 75 - Related articles - BL Direct - All 5 versions

Long-term risk of cardiovascular events with rosiglitazone: a meta-analysis

- infodiabetes.it [PDF] 
S Singh, YK Loke, CD Furberg - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Recent reports of ...
Cited by 304 - Related articles - BL Direct - All 12 versions

Congestive heart failure and cardiovascular death in patients with prediabetes and type 2 …


RM Lago, PP Singh, RW Nesto - The Lancet, 2007 - Elsevier
360 of 20 191 patients who had either prediabetes or type 2 diabetes had
congestive heart failure events (214 with TZDs and 146 with comparators).
Results showed no heterogeneity of effects across studies (I 2 =22ยท8%; p ...
Cited by 180 - Related articles - BL Direct - All 7 versions

A comparison of pioglitazone and rosiglitazone for hospitalization for acute myocardial …


CM Gerrits, M Bhattacharya, S Manthena, R … - Pharmacoepidemiology and drug safety, 2007 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ...
Cited by 61 - Related articles - BL Direct - All 4 versions

Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus: a …


AM Lincoff, K Wolski, SJ Nicholls, SE Nissen - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Pioglitazone is ...
Cited by 325 - Related articles - BL Direct - All 7 versions

Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis

- infodiabetes.it [PDF] 
PD Home, SJ Pocock, H Beck-Nielsen, R … - New England Journal of Medicine, 2007 - content.nejm.org
From Newcastle Diabetes Centre and Newcastle University, Newcastle upon Tyne,
United Kingdom (PDH); the Med- ical Statistics Unit, London School of Hy- giene
and Tropical Medicine, London (SJP); the Department of Endocrinolo- gy and ...
Cited by 497 - Related articles - BL Direct - All 15 versions

Rosiglitazone: A Thunderstorm from Scarce and Fragile Data

- usafp.org [PDF] 
T Rumbles, L Strikes, F Remains - Annals of Internal Medicine - Am Coll Physicians
T he US Food and Drug Administration (FDA) has approved many pharmacotherapies
for treating diabe- tes on the basis of the drugs' ability to improve glycemic
control. Although preventing adverse macrovascular out- comes, such as ...
Related articles - All 2 versions

Rosiglitazone for type 2 diabetes mellitus.


B Richter, E Bandeira-Echtler, K Bergerhoff, … - Cochrane database of systematic reviews (Online), 2007 - ncbi.nlm.nih.gov
BACKGROUND: Diabetes has long been recognised as a strong, independent risk
factor for cardiovascular disease, a problem which accounts for approximately
70% of all mortality in people with diabetes. Prospective studies show that ...
Cited by 55 - Related articles

Thiazolidinediones and cardiovascular outcomes in older patients with diabetes

- infodiabetes.it [PDF] 
LL Lipscombe, T Gomes, LE Levesque, JE Hux, … - Jama, 2007 - Am Med Assoc
You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better.
Cited by 117 - Related articles - BL Direct - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google